Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHEVRON CORPCVX · Entity 2804 | Director | May 22, 2003 | December 04, 2003 |
| STANDARD BIOTOOLS INC.FLDM · Entity 6116 | Director | July 31, 2017 | August 03, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHEVRON CORP
Report date May 22, 2003 · Filed December 04, 2003 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,612 |
Reported balance
After 2003-05-22 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2003-05-22 · Grant · Acquired 1,579 · Balance 10,612 F1: Effective January 1, 2002, the retainer paid to non-employee Directors was $100,000 per annum ($75,000 in cash and $25,000 in dollar denominated deferred stock units). The deferred stock units were credited to the non-employee Directors' accounts quarterly and reported on Form 4s in 2002 and through the 1st and 2nd quarter of 2003. Effective May 22, 2003, the deferred stock units were credited to the non-employee Directors' accounts in a lump sum. Therefore, the number of deferred stock units reported on the Form 4 filed May 22, 2003 was overstated by 191 deferred stock units (the allocations for the 1st and 2nd quarter of 2003). The reporting person is filing an amended Form 4 to reflect the correct number of deferred stock units owned as of May 22, 2003. F2: This number includes dividend equivalent accruals under the Non-Employee Directors' Equity Compensation and Deferral Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Effective January 1, 2002, the retainer paid to non-employee Directors was $100,000 per annum ($75,000 in cash and $25,000 in dollar denominated deferred stock units). The deferred stock units were credited to the non-employee Directors' accounts quarterly and reported on Form 4s in 2002 and through the 1st and 2nd quarter of 2003. Effective May 22, 2003, the deferred stock units were credited to the non-employee Directors' accounts in a lump sum. Therefore, the number of deferred stock units reported on the Form 4 filed May 22, 2003 was overstated by 191 deferred stock units (the allocations for the 1st and 2nd quarter of 2003). The reporting person is filing an amended Form 4 to reflect the correct number of deferred stock units owned as of May 22, 2003.
F2: This number includes dividend equivalent accruals under the Non-Employee Directors' Equity Compensation and Deferral Plan.
STANDARD BIOTOOLS INC.
Report date July 31, 2017 · Filed August 03, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectYoung Family Trust | 5,849 |
Reported balance
After 2017-07-31 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2017-07-31 · Exercise / conversion · Acquired 5,000 · Balance 5,849 F1: Shares held indirectly by the Young Family Trust dated September 8, 1986, a trust for the benefit of the Reporting Person and the Reporting Person's spouse, for which the Reporting Person and the Reporting Person's spouse serve as trustees. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2017-07-31 | Direct | 0 |
Reported balance
After 2017-07-31 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-07-31 · Exercise / conversion · Disposed 5,000 · Balance 0 F2: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares held indirectly by the Young Family Trust dated September 8, 1986, a trust for the benefit of the Reporting Person and the Reporting Person's spouse, for which the Reporting Person and the Reporting Person's spouse serve as trustees.
F2: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 31, 2017 Filed Aug 3, 2017 00:35 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000086 · wf-form4_150172051793070.xml · derivative · entry 2 YOUNG JOHN A · CIK 0001194929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Restricted Stock Units · 5,000 shares Expires 2017-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. Read SEC document |
| July 31, 2017 Filed Aug 3, 2017 00:35 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000086 · wf-form4_150172051793070.xml · nonDerivative · entry 1 YOUNG JOHN A · CIK 0001194929 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Young Family Trust Disclosed balance after: 5,849 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Shares held indirectly by the Young Family Trust dated September 8, 1986, a trust for the benefit of the Reporting Person and the Reporting Person's spouse, for which the Reporting Person and the Reporting Person's spouse serve as trustees. Read SEC document |
| May 22, 2003 Filed Dec 4, 2003 23:51 UTC Amendment | CHEVRON CORP CVX · Entity 2804 | GrantCommon Stock | 1,579 | $67.45 | $106,503.55 |
DisclosureSEC source: 0000093410-03-000023 · edgar.xml · nonDerivative · entry 1 YOUNG JOHN A · CIK 0001194929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,612 F1 · shares: Effective January 1, 2002, the retainer paid to non-employee Directors was $100,000 per annum ($75,000 in cash and $25,000 in dollar denominated deferred stock units). The deferred stock units were credited to the non-employee Directors' accounts quarterly and reported on Form 4s in 2002 and through the 1st and 2nd quarter of 2003. Effective May 22, 2003, the deferred stock units were credited to the non-employee Directors' accounts in a lump sum. Therefore, the number of deferred stock units reported on the Form 4 filed May 22, 2003 was overstated by 191 deferred stock units (the allocations for the 1st and 2nd quarter of 2003). The reporting person is filing an amended Form 4 to reflect the correct number of deferred stock units owned as of May 22, 2003. F2 · balance_after: This number includes dividend equivalent accruals under the Non-Employee Directors' Equity Compensation and Deferral Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.